Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Stock-based Compensation

v3.24.3
Note 12 - Stock-based Compensation
9 Months Ended
Sep. 30, 2024
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

12.         Stock-based Compensation

 

Shares available for grant

 

The Company's Amended and Restated 2014 Equity Incentive Plan (the "2014 Plan") expired on  January 31, 2024. Following such expiration and prior to the 2024 Annual Meeting of Stockholders (the "Annual Meeting")no grants were made under the 2014 Plan. On June 6, 2024, the Company held its Annual Meeting and amended and restated the 2014 Plan (the "Restated 2014 Plan") to extend the term of the 2014 Plan until April 15, 2034, and to increase the total number of shares of common stock authorized for issuance by 1,000 shares relative to the amount available for issuance at the time the 2014 Plan expired. As of September 30, 2024, the total number of shares authorized for grant under the Restated 2014 Plan was 4,724, of which 980 were available for future grants.

 

Stock Options

 

The following table summarizes information about the Company’s stock options outstanding as of September 30, 2024, and activity during the nine months then ended:

 

                   

Weighted-

         
                   

Average

         
           

Weighted-

   

Remaining

   

Aggregate

 
   

Stock

   

Average

   

Contractual

   

Intrinsic

 
   

Awards

   

Exercise Price

   

Life (Years)

   

Value

 

Balance as of December 31, 2023

    252     $ 36.17                  

Options cancelled

    (67 )     45.30                  

Balance as of September 30, 2024

    185     $ 32.90       3.80     $  

Vested and expected to vest as of September 30, 2024

    185     $ 32.90       3.79     $  

Exercisable as of September 30, 2024

    185     $ 32.91       3.80     $  

 

There were no stock options awarded during the three and nine months ended September 30, 2024 and 2023, and no unrecognized compensation cost related to unvested stock options as of September 30, 2024.

 

Restricted Stock Units

 

The Company issues time-based restricted stock units (“RSUs”) and performance-based restricted stock units ("PSUs") to employees and non-employees. Each RSU and PSU represents the right to receive one share of the Company’s common stock upon vesting and subsequent settlement. PSUs vest upon achievement of performance targets based on the Company's annual operating plan. The fair values of RSUs and PSUs are determined based on the closing price of the Company’s common stock on the date of grant.

 

Combined RSU and PSU activity for the nine months ended September 30, 2024 is summarized below:

 

           

Weighted-

 
   

Number of

   

Average Grant

 
   

Shares

   

Date Fair Value

 

Unvested as of December 31, 2023

    1,305     $ 1.67  

Granted

    413       1.12  

Vested

    (635 )     1.95  

Forfeited

    (49 )     1.76  

Unvested as of September 30, 2024

    1,034     $ 1.30  

 

As of September 30, 2024, $722 of total unrecognized compensation expense related to unvested RSUs and PSUs was expected to be recognized over a weighted average period of 0.97 years.

 

Compensation Expense

 

Stock-based compensation expense is included in the condensed consolidated statements of operations and comprehensive loss in general and administrative, research and development, or sales and marketing expenses, depending on the nature of the services provided. Stock-based compensation expense related to RSUs and PSUs was recorded as follows:

 

   

Three Months Ended September 30,

   

Nine Months Ended September 30,

 
   

2024

   

2023

   

2024

   

2023

 

Sales and marketing

  $ 22     $ 69     $ 80     $ 209  

Research and development

    27       107       198       320  

General and administrative

    357       265       788       850  
    $ 406     $ 441     $ 1,066     $ 1,379  

 

401(k) Plan Share Match

 

During the nine months ended September 30, 2024 and 2023, the Company issued 163 and 161 shares of common stock with a fair value of $237 and $249, respectively, to eligible employees’ deferral accounts for the 401(k) Plan matching contribution representing 50% of each eligible employee’s elected deferral (up to the statutory limit) for the years ended December 31, 2023 and 2022.

 

The expense for the 401(k) Plan share matching was $177 and $304 for the nine months ended September 30, 2024 and 2023, respectively.